Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
MARCKSL1	65108	broad.mit.edu	37	1	32801650	32801650	+	5'UTR	SNP	G	G	A			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr1:32801650G>A	ENST00000329421.7	-	0	330					NM_023009.6	NP_075385.1	P49006	MRP_HUMAN	MARCKS-like 1	NA		NA		NA		plasma membrane	calmodulin binding			breast(1)|large_intestine(3)|lung(1)|ovary(1)	6		Myeloproliferative disorder(586;0.0393)|all_neural(195;0.186)				GGGTCTGCTGGGGGGCGCTTG	0.781	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													9	11	11	NA	NA	NA	NA	1		NA								NA			NA				32801650		1598	3452	5050	SO:0001623	5_prime_UTR_variant			ENSG00000175130	HGNC:7142	NM_023009	Approved	uc001bvd.4	NA	D3DPQ0|Q5TEE6|Q6NXS5	ENST00000329421.7	37	CCDS361.1																																																																																			MARCKSL1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000020059.3	6.077103	KEEP		-	10.232484	0.129032	4	27	---	---	---	---	1	0.9999998	49	366	0	41	6	33	0	41	2	0	0	0	0	0	0	6	33	0	41	2	TP
PSMD4	5710	broad.mit.edu	37	1	151237667	151237667	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr1:151237667A>G	ENST00000368884.3	+	5	475	c.395A>G	c.(394-396)aAg>aGg	p.K132R	PSMD4_ENST00000368881.4_Missense_Mutation_p.K132R	NM_002810.2	NP_002801.1	P55036	PSMD4_HUMAN	proteasome (prosome, macropain) 26S subunit, non-ATPase, 4	132	VWFA.	NA		NA	anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process|apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA repair|G1/S transition of mitotic cell cycle|M/G1 transition of mitotic cell cycle|mRNA metabolic process|negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|regulation of apoptosis|regulation of cellular amino acid metabolic process|regulation of transcription, DNA-dependent|S phase of mitotic cell cycle|viral reproduction	proteasome complex	protein binding|zinc ion binding			breast(2)|endometrium(1)|kidney(1)|lung(7)	11	Lung SC(34;0.00471)|Ovarian(49;0.0147)|Hepatocellular(266;0.0997)|all_hematologic(923;0.127)|Melanoma(130;0.185)		UCEC - Uterine corpus endometrioid carcinoma (35;0.112)|LUSC - Lung squamous cell carcinoma(543;0.181)			AAACGCCTCAAGAAGGAGAAA	0.453	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													74	69	71	NA	NA	NA	NA	1		NA								NA			NA				151237667		2203	4300	6503	SO:0001583	missense			ENSG00000159352	HGNC:9561	NM_002810	Approved	uc001exl.3	NA	D3DV16|Q5VWC5|Q9NS92	ENST00000368884.3	37	CCDS991.1	.	.	.	.	.	.	.	.	.	.	A	32	5.172458	0.94807	.	.	ENSG00000159352	ENST00000368884;ENST00000368881;ENST00000437736	T;T;T	0.15256	2.44;2.44;2.44	5.44	5.44	0.79542	Ssl1-like (1);von Willebrand factor, type A (2);	0.000000	0.85682	D	0.000000	T	0.33498	0.0865	M	0.76938	2.355	0.80722	D	1	D;D	0.76494	0.999;0.999	D;D	0.70016	0.967;0.967	T	0.08493	-1.0719	10	0.49607	T	0.09	-31.6528	15.3268	0.74172	1.0:0.0:0.0:0.0	.	132;132	Q5VWC4;P55036	.;PSMD4_HUMAN	R	132;132;117	ENSP00000357879:K132R;ENSP00000357876:K132R;ENSP00000414499:K117R	ENSP00000357876:K132R	K	+	2	0	PSMD4	149504291	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	8.501000	0.90501	2.288000	0.76882	0.533000	0.62120	AAG	PSMD4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000034409.3	-6.106154	KEEP		+	13.703749	0.053191	5	89	---	---	---	---	1	0.9999655	12	694	0	83	5	104	0	83	2	0	0	0	0	0	0	5	104	0	83	2	TP
PRG4	10216	broad.mit.edu	37	1	186282107	186282107	+	Intron	SNP	A	A	G			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr1:186282107A>G	ENST00000445192.2	+	12	4162				RNU6-1240P_ENST00000365155.1_RNA|PRG4_ENST00000367486.3_Intron|PRG4_ENST00000367485.4_Intron|PRG4_ENST00000367484.3_Intron|PRG4_ENST00000367483.4_Intron	NM_005807.3	NP_005798.2	Q92954	PRG4_HUMAN	proteoglycan 4	NA		NA		NA	cell proliferation|immune response	extracellular region	polysaccharide binding|protein binding|scavenger receptor activity			NS(2)|breast(1)|central_nervous_system(1)|endometrium(26)|haematopoietic_and_lymphoid_tissue(1)|kidney(7)|large_intestine(12)|lung(33)|prostate(7)|skin(9)|upper_aerodigestive_tract(2)|urinary_tract(1)	102						GCTGGCTGCAATGATGACTGA	0.333	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													NA	NA	NA	NA	NA	NA	NA			NA								NA			NA				NA		NA	NA	NA	SO:0001627	intron_variant			ENSG00000116690	HGNC:9364	NM_005807	Approved	uc001gru.4	NA	Q6DNC4|Q6DNC5|Q6ZMZ5|Q9BX49	ENST00000445192.2	37	CCDS1369.1																																																																																			PRG4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000086346.1	131.40629	KEEP		+	131.409464	0.507042	36	35	---	---	---	---	1	0.9999978	7	21	0	72	36	35	0	72	2	0	0	0	0	0	0	36	35	0	72	2	TP
GPN1	11321	broad.mit.edu	37	2	27861753	27861753	+	Splice_Site	SNP	C	C	T			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr2:27861753C>T	ENST00000264718.3	+	9	635	c.612_splice	c.e9-1	p.T205_splice	GPN1_ENST00000458167.2_Splice_Site_p.T96_splice|GPN1_ENST00000503738.1_Splice_Site_p.T96_splice|GPN1_ENST00000407583.3_Splice_Site_p.T179_splice|GPN1_ENST00000461249.1_3'UTR|GPN1_ENST00000424214.1_Splice_Site_p.T112_splice|GPN1_ENST00000515877.1_Splice_Site_p.T112_splice	NM_007266.3	NP_009197.2	Q9HCN4	GPN1_HUMAN	GPN-loop GTPase 1	191		NA		NA		cytoplasm	GTP binding|nucleoside-triphosphatase activity|protein binding			endometrium(1)|large_intestine(1)|lung(12)	14						CTGGTACAGACTGACATCATT	0.393	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													109	97	101	NA	NA	NA	NA	2		NA								NA			NA				27861753		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000198522	HGNC:17030	NM_007266	Approved	uc010ymc.2	NA	O76004	ENST00000264718.3	37	CCDS1760.2	.	.	.	.	.	.	.	.	.	.	C	15.79	2.936816	0.52972	.	.	ENSG00000198522	ENST00000515877;ENST00000503738;ENST00000458167;ENST00000424214;ENST00000407583;ENST00000264718	T;T;T;T;T;T	0.19532	2.14;2.14;2.14;2.14;2.14;2.14	5.85	5.85	0.93711	.	0.000000	0.85682	D	0.000000	T	0.11067	0.0270	N	0.01417	-0.88	0.80722	D	1	B;B;B;B	0.27951	0.195;0.17;0.085;0.053	B;B;B;B	0.40659	0.085;0.336;0.241;0.096	T	0.25882	-1.0119	10	0.06365	T	0.9	-14.4529	16.8827	0.86067	0.0:1.0:0.0:0.0	.	191;205;96;179	Q9HCN4;B4DQM4;B4DXU4;B5MBZ5	GPN1_HUMAN;.;.;.	I	112;96;96;112;179;205	ENSP00000424678:T112I;ENSP00000427269:T96I;ENSP00000412170:T96I;ENSP00000398115:T112I;ENSP00000384255:T179I;ENSP00000264718:T205I	ENSP00000264718:T205I	T	+	2	0	GPN1	27715257	1.000000	0.71417	1.000000	0.80357	0.977000	0.68977	7.175000	0.77632	2.773000	0.95371	0.655000	0.94253	ACT	GPN1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000215027.2	2.617783	KEEP	Missense_Mutation	+	24.866303	0.085937	11	117	---	---	---	---	1	0.998032	21	104	0	186	12	135	0	186	2	0	0	0	0	0	0	12	135	0	186	2	TP
ZDBF2	57683	broad.mit.edu	37	2	207171009	207171009	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr2:207171009A>G	ENST00000374423.3	+	5	2143	c.1757A>G	c.(1756-1758)gAt>gGt	p.D586G		NM_020923.1	NP_065974.1	Q9HCK1	ZDBF2_HUMAN	zinc finger, DBF-type containing 2	586		NA		NA			nucleic acid binding|zinc ion binding			endometrium(4)|kidney(5)|large_intestine(28)|lung(50)|ovary(4)|prostate(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	95						TTTGATTGTGATGTTTCTCTT	0.428	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													109	95	99	NA	NA	NA	NA	2		NA								NA			NA				207171009		1888	4115	6003	SO:0001583	missense			ENSG00000204186	HGNC:29313	NM_020923	Approved	uc002vbp.2	NA	Q6ZNP7|Q6ZSN8	ENST00000374423.3	37	CCDS46501.1	.	.	.	.	.	.	.	.	.	.	A	16.68	3.189333	0.57909	.	.	ENSG00000204186	ENST00000374423	T	0.45276	0.9	4.09	1.72	0.24424	.	0.173462	0.27896	N	0.017413	T	0.31670	0.0804	M	0.64404	1.975	0.09310	N	1	P	0.43024	0.798	B	0.39465	0.3	T	0.18241	-1.0343	10	0.11794	T	0.64	.	5.9527	0.19255	0.8021:0.0:0.1979:0.0	.	586	Q9HCK1	ZDBF2_HUMAN	G	586	ENSP00000363545:D586G	ENSP00000363545:D586G	D	+	2	0	ZDBF2	206879254	0.096000	0.21769	0.069000	0.20011	0.980000	0.70556	0.404000	0.20999	0.385000	0.24970	0.528000	0.53228	GAT	ZDBF2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000336458.1	76.968477	KEEP		+	80.739983	0.27907	24	62	---	---	---	---	1	0.6562592	2	5	0	107	29	70	0	107	2	0	0	0	0	0	0	29	70	0	107	2	TP
SETD2	29072	broad.mit.edu	37	3	47127761	47127761	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr3:47127761T>C	ENST00000409792.3	-	11	5363	c.5321A>G	c.(5320-5322)cAt>cGt	p.H1774R	SETD2_ENST00000492397.1_5'Flank|snoU13_ENST00000516129.1_RNA	NM_014159.6	NP_054878.5	Q9BYW2	SETD2_HUMAN	SET domain containing 2	1774		NA		NA	regulation of transcription, DNA-dependent|transcription, DNA-dependent	chromosome|nucleus	DNA binding|histone-lysine N-methyltransferase activity|oxidoreductase activity|transition metal ion binding			breast(6)|central_nervous_system(5)|endometrium(4)|kidney(63)|large_intestine(18)|lung(26)|ovary(6)|prostate(2)|skin(3)|soft_tissue(1)|stomach(2)|urinary_tract(5)	141		Acute lymphoblastic leukemia(5;0.0169)		BRCA - Breast invasive adenocarcinoma(193;0.000302)|KIRC - Kidney renal clear cell carcinoma(197;0.00732)|Kidney(197;0.00844)		AGACAGCCCATGACGTTCCAG	0.498	NA	NA	"""N, F, S, Mis"""		clear cell renal carcinoma		NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Rec	yes		3	3p21.31	29072	SET domain containing 2	NA	E	0													139	120	126	NA	NA	NA	NA	3		NA								NA			NA				47127761		2203	4300	6503	SO:0001583	missense			ENSG00000181555	HGNC:18420	NM_014159	Approved	uc003cqs.3	NA	O75397|O75405|Q17RW8|Q5BKS9|Q5QGN2|Q69YI5|Q6IN64|Q6ZN53|Q6ZS25|Q8N3R0|Q8TCN0|Q9C0D1|Q9H696|Q9NZW9	ENST00000409792.3	37	CCDS2749.2	.	.	.	.	.	.	.	.	.	.	T	25.1	4.600233	0.87055	.	.	ENSG00000181555	ENST00000451092;ENST00000409792	D	0.90133	-2.62	5.47	5.47	0.80525	.	0.000000	0.64402	D	0.000019	D	0.94857	0.8338	M	0.76170	2.325	0.80722	D	1	D;D	0.76494	0.999;0.999	D;D	0.80764	0.994;0.994	D	0.95203	0.8318	10	0.62326	D	0.03	.	15.5762	0.76387	0.0:0.0:0.0:1.0	.	1774;1774	F2Z317;Q9BYW2	.;SETD2_HUMAN	R	1774	ENSP00000386759:H1774R	ENSP00000386759:H1774R	H	-	2	0	SETD2	47102765	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	7.477000	0.81069	2.081000	0.62600	0.528000	0.53228	CAT	SETD2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000257479.2	106.067754	KEEP		-	112.241046	0.278571	39	101	---	---	---	---	1	0.9999988	16	45	0	110	41	109	0	110	2	0	0	0	0	0	0	41	109	0	110	2	TP
SLMAP	7871	broad.mit.edu	37	3	57898233	57898233	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr3:57898233G>T	ENST00000295951.3	+	18	2940	c.1723G>T	c.(1723-1725)Gca>Tca	p.A575S	SLMAP_ENST00000428312.1_Missense_Mutation_p.A592S|SLMAP_ENST00000494088.1_Missense_Mutation_p.A85S|SLMAP_ENST00000295952.3_Missense_Mutation_p.A575S|SLMAP_ENST00000495364.1_Missense_Mutation_p.A126S|SLMAP_ENST00000472546.1_3'UTR|SLMAP_ENST00000449503.2_Missense_Mutation_p.A554S|SLMAP_ENST00000442599.2_Missense_Mutation_p.A60S|SLMAP_ENST00000416870.1_Missense_Mutation_p.A85S			Q14BN4	SLMAP_HUMAN	sarcolemma associated protein	592		NA		NA	muscle contraction|protein folding	integral to plasma membrane|microtubule organizing center|prefoldin complex|sarcolemma|smooth endoplasmic reticulum	unfolded protein binding			endometrium(5)|kidney(1)|large_intestine(3)|lung(7)|urinary_tract(2)	18				BRCA - Breast invasive adenocarcinoma(55;0.000271)|KIRC - Kidney renal clear cell carcinoma(284;0.0602)|Kidney(284;0.0754)|OV - Ovarian serous cystadenocarcinoma(275;0.182)		TCAAGCAGCAGCAAAGGTTGC	0.483	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													97	92	94	NA	NA	NA	NA	3		NA								NA			NA				57898233		2203	4300	6503	SO:0001583	missense			ENSG00000163681	HGNC:16643	NM_007159	Approved	uc003djd.1	NA	Q14C95|Q6AI54|Q6UXC9|Q6ZVQ8|Q8NCW9|Q9H297|Q9HCH1|Q9Y681	ENST00000295951.3	37	CCDS33774.1	.|.|.	.|.|.	.|.|.	.|.|.	.|.|.	.|.|.	.|.|.	.|.|.	.|.|.	.|.|.	G|G|G	21.0|21.0|21.0	4.078792|4.078792|4.078792	0.76528|0.76528|0.76528	.|.|.	.|.|.	ENSG00000163681|ENSG00000163681|ENSG00000163681	ENST00000295951;ENST00000295952;ENST00000416870;ENST00000428312;ENST00000449503;ENST00000537224;ENST00000442599;ENST00000495364;ENST00000494088;ENST00000466255|ENST00000417128|ENST00000416658;ENST00000438794	T;T;T;T;T;T;T;T|.|.	0.43294|.|.	0.95;0.95;0.95;1.53;0.95;0.95;0.95;0.95|.|.	5.18|5.18|5.18	5.18|5.18|5.18	0.71444|0.71444|0.71444	Prefoldin beta-like (1);|.|.	0.204155|.|.	0.49916|.|.	D|.|.	0.000122|.|.	T|T|T	0.47911|0.47911|0.47911	0.1471|0.1471|0.1471	L|L|L	0.29908|0.29908|0.29908	0.895|0.895|0.895	0.26158|0.26158|0.26158	N|N|N	0.980049|0.980049|0.980049	B;B;B;B;B;B;B;B|.|.	0.22541|.|.	0.036;0.014;0.029;0.071;0.015;0.023;0.009;0.023|.|.	B;B;B;B;B;B;B;B|.|.	0.36092|.|.	0.217;0.013;0.087;0.167;0.087;0.012;0.011;0.029|.|.	T|T|T	0.41574|0.41574|0.41574	-0.9501|-0.9501|-0.9501	10|5|5	0.46703|.|.	T|.|.	0.11|.|.	-0.578|-0.578|-0.578	19.0507|19.0507|19.0507	0.93043|0.93043|0.93043	0.0:0.0:1.0:0.0|0.0:0.0:1.0:0.0|0.0:0.0:1.0:0.0	.|.|.	85;60;126;85;186;554;592;575|.|.	B7Z863;C9JPE6;Q14BN4-5;Q14BN4-8;Q14BN4-4;Q14BN4-2;Q14BN4;Q14BN4-3|.|.	.;.;.;.;.;.;SLMAP_HUMAN;.|.|.	S|H|I	575;575;85;592;554;186;60;126;85;85|175|199;129	ENSP00000295951:A575S;ENSP00000295952:A575S;ENSP00000412342:A85S;ENSP00000398661:A592S;ENSP00000412945:A554S;ENSP00000388978:A60S;ENSP00000419543:A126S;ENSP00000418218:A85S|.|.	ENSP00000295951:A575S|.|.	A|Q|S	+|+|+	1|3|2	0|2|0	SLMAP|SLMAP|SLMAP	57873273|57873273|57873273	1.000000|1.000000|1.000000	0.71417|0.71417|0.71417	1.000000|1.000000|1.000000	0.80357|0.80357|0.80357	0.963000|0.963000|0.963000	0.63663|0.63663|0.63663	5.121000|5.121000|5.121000	0.64691|0.64691|0.64691	2.584000|2.584000|2.584000	0.87258|0.87258|0.87258	0.561000|0.561000|0.561000	0.74099|0.74099|0.74099	GCA|CAG|AGC	SLMAP-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000258230.1	327.519599	KEEP		+	328.787703	0.590909	104	72	---	---	---	---	1	1	36	24	0	147	114	86	0	147	2	0	0	0	0	0	0	114	86	0	147	2	TP
ANK2	287	broad.mit.edu	37	4	114274951	114274951	+	Missense_Mutation	SNP	C	C	A			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr4:114274951C>A	ENST00000357077.4	+	38	5230	c.5177C>A	c.(5176-5178)gCt>gAt	p.A1726D	ANK2_ENST00000264366.6_Missense_Mutation_p.A1693D|ANK2_ENST00000506722.1_Intron|ANK2_ENST00000394537.3_Intron|ANK2_ENST00000509550.1_Intron|ANK2_ENST00000510275.2_Intron	NM_001148.4	NP_001139.3	Q01484	ANK2_HUMAN	ankyrin 2, neuronal	1693		NA		NA	axon guidance|signal transduction	apical plasma membrane|basolateral plasma membrane|cytoskeleton|cytosol|sarcomere	protein binding			NS(1)|biliary_tract(1)|breast(9)|central_nervous_system(10)|cervix(2)|endometrium(6)|haematopoietic_and_lymphoid_tissue(2)|kidney(7)|large_intestine(54)|liver(2)|lung(112)|ovary(8)|pancreas(1)|prostate(7)|skin(11)|stomach(2)|upper_aerodigestive_tract(3)|urinary_tract(10)	248		Ovarian(17;0.0448)|Hepatocellular(203;0.218)		OV - Ovarian serous cystadenocarcinoma(123;4.92e-05)		GCAGAGAAAGCTGAACTTAAA	0.418	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													197	206	203	NA	NA	NA	NA	4		NA								NA			NA				114274951		2203	4300	6503	SO:0001583	missense			ENSG00000145362	HGNC:493	NM_001148	Approved	uc003ibe.4	NA	Q01485|Q08AC7|Q08AC8|Q7Z3L5	ENST00000357077.4	37	CCDS3702.1	.	.	.	.	.	.	.	.	.	.	C	3.271	-0.149202	0.06585	.	.	ENSG00000145362	ENST00000357077;ENST00000264366	T;T	0.66638	-0.21;-0.22	5.7	2.1	0.27182	.	1.689100	0.03159	N	0.169118	T	0.49745	0.1575	N	0.14661	0.345	0.09310	N	1	B;B	0.23249	0.029;0.082	B;B	0.23852	0.014;0.049	T	0.31833	-0.9929	9	.	.	.	.	5.9837	0.19421	0.0:0.5832:0.1333:0.2835	.	1693;1726	Q01484;Q01484-4	ANK2_HUMAN;.	D	1726;1693	ENSP00000349588:A1726D;ENSP00000264366:A1693D	.	A	+	2	0	ANK2	114494400	0.000000	0.05858	0.000000	0.03702	0.185000	0.23345	0.003000	0.13083	0.076000	0.16826	0.655000	0.94253	GCT	ANK2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256422.2	-138.012689	KEEP		+	6.973824	0.011342	6	523	---	---	---	---	1	0.1257177	50	0	0	560	6	577	0	560	2	0	0	0	0	0	0	6	577	0	560	2	TP
KIAA1109	84162	broad.mit.edu	37	4	123238013	123238013	+	Missense_Mutation	SNP	C	C	G			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr4:123238013C>G	ENST00000264501.4	+	62	11039	c.10666C>G	c.(10666-10668)Ctg>Gtg	p.L3556V	KIAA1109_ENST00000388738.3_Missense_Mutation_p.L3556V|KIAA1109_ENST00000455637.1_Missense_Mutation_p.L3556V			Q2LD37	K1109_HUMAN	KIAA1109	3556		NA		NA	regulation of cell growth|regulation of epithelial cell differentiation	integral to membrane|nucleus				breast(7)|central_nervous_system(1)|cervix(1)|endometrium(16)|kidney(6)|large_intestine(33)|liver(4)|lung(74)|ovary(9)|pancreas(1)|prostate(5)|skin(6)|upper_aerodigestive_tract(6)|urinary_tract(3)	172						AATAGATGATCTGAAGTATGT	0.328	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													88	88	88	NA	NA	NA	NA	4		NA								NA			NA				123238013		1822	4084	5906	SO:0001583	missense			ENSG00000138688	HGNC:26953	NM_020797	Approved	uc003ieh.3	NA	Q4W598|Q5CZA9|Q6ZS70|Q6ZV75|Q86XA5|Q8WVD8|Q9H742|Q9NT48|Q9NTC3|Q9NTI4|Q9P2H6|Q9UPP3	ENST00000264501.4	37	CCDS43267.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	20.7|20.7	4.034719|4.034719	0.75617|0.75617	.|.	.|.	ENSG00000138688|ENSG00000138688	ENST00000264501;ENST00000388738;ENST00000455637;ENST00000438707|ENST00000419325	T;T;T;T|.	0.61040|.	0.94;0.94;0.38;0.14|.	5.61|5.61	5.61|5.61	0.85477|0.85477	.|.	0.000000|.	0.64402|.	D|.	0.000007|.	T|T	0.72431|0.72431	0.3459|0.3459	M|M	0.68593|0.68593	2.085|2.085	0.54753|0.54753	D|D	0.99998|0.99998	D;D|.	0.69078|.	0.996;0.997|.	D;D|.	0.75484|.	0.986;0.978|.	T|T	0.71351|0.71351	-0.4619|-0.4619	10|5	0.87932|.	D|.	0|.	.|.	14.8521|14.8521	0.70306|0.70306	0.0:0.9294:0.0:0.0706|0.0:0.9294:0.0:0.0706	.|.	3556;3556|.	Q2LD37-6;Q2LD37|.	.;K1109_HUMAN|.	V|C	3556;3556;3556;239|1513	ENSP00000264501:L3556V;ENSP00000373390:L3556V;ENSP00000389925:L3556V;ENSP00000410874:L239V|.	ENSP00000264501:L3556V|.	L|S	+|+	1|2	2|0	KIAA1109|KIAA1109	123457463|123457463	1.000000|1.000000	0.71417|0.71417	0.997000|0.997000	0.53966|0.53966	0.937000|0.937000	0.57800|0.57800	4.655000|4.655000	0.61476|0.61476	2.637000|2.637000	0.89404|0.89404	0.655000|0.655000	0.94253|0.94253	CTG|TCT	KIAA1109-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000316415.1	121.913327	KEEP		+	122.185896	0.4375	35	45	---	---	---	---	1	0.9679754	5	5	0	110	41	52	0	110	2	0	0	0	0	0	0	41	52	0	110	2	TP
PIK3R1	5295	broad.mit.edu	37	5	67588923	67588923	+	Intron	SNP	T	T	G			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr5:67588923T>G	ENST00000521381.1	+	9	1635				PIK3R1_ENST00000521657.1_Intron|PIK3R1_ENST00000523872.1_Intron|PIK3R1_ENST00000320694.8_Intron|PIK3R1_ENST00000274335.5_Intron|PIK3R1_ENST00000396611.1_Intron|PIK3R1_ENST00000336483.5_Intron	NM_181523.2	NP_852664.1	P27986	P85A_HUMAN	phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	NA		NA		NA	epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|growth hormone receptor signaling pathway|insulin receptor signaling pathway|insulin-like growth factor receptor signaling pathway|interspecies interaction between organisms|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol 3-kinase cascade|phosphatidylinositol phosphorylation|phosphatidylinositol-mediated signaling|platelet activation|positive regulation of establishment of protein localization in plasma membrane|positive regulation of glucose import|T cell costimulation|T cell receptor signaling pathway	1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex	1-phosphatidylinositol binding|ErbB-3 class receptor binding|insulin binding|insulin receptor binding|insulin receptor substrate binding|insulin-like growth factor receptor binding|phosphatidylinositol 3-kinase regulator activity|protein phosphatase binding	p.?(2)|p.0?(1)		breast(12)|central_nervous_system(31)|cervix(1)|endometrium(68)|haematopoietic_and_lymphoid_tissue(5)|kidney(1)|large_intestine(32)|lung(10)|ovary(9)|pancreas(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(3)|urinary_tract(2)	178		Lung NSC(167;1.99e-05)|Prostate(74;0.00308)|Ovarian(174;0.00473)|Colorectal(97;0.0176)		OV - Ovarian serous cystadenocarcinoma(47;3.76e-51)|Lung(70;0.0211)	Isoproterenol(DB01064)	TGTGTTTTCATTTCAGGGAAG	0.348	NA	NA	"""Mis, F, O"""		"""gliobastoma, ovarian, colorectal"""		NA			TCGA GBM(4;<1E-08)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Rec	yes		5	5q13.1	5295	"""phosphoinositide-3-kinase, regulatory subunit 1 (alpha)"""	NA	"""E, O"""	3	Unknown(2)|Whole gene deletion(1)	large_intestine(1)|lung(1)|endometrium(1)											71	71	71	NA	NA	NA	NA	5		NA								NA			NA				67588923		2203	4300	6503	SO:0001627	intron_variant			ENSG00000145675	HGNC:8979	NM_181504	Approved	uc003jva.3	NA	D3DWA0|Q15747|Q4VBZ7|Q53EM6|Q8IXA2|Q8N1C5	ENST00000521381.1	37	CCDS3993.1																																																																																			PIK3R1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000254013.2	154.944886	KEEP		+	156.284691	0.381818	42	68	---	---	---	---	1	0.9989113	22	0	0	101	45	77	0	101	2	0	0	0	0	0	0	45	77	0	101	2	TP
ZNF608	57507	broad.mit.edu	37	5	124080387	124080387	+	Missense_Mutation	SNP	T	T	G			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr5:124080387T>G	ENST00000306315.5	-	1	731	c.296A>C	c.(295-297)aAa>aCa	p.K99T	ZNF608_ENST00000504926.1_5'Flank	NM_020747.2	NP_065798.2	Q9ULD9	ZN608_HUMAN	zinc finger protein 608	99		NA		NA		intracellular	zinc ion binding			breast(4)|endometrium(4)|haematopoietic_and_lymphoid_tissue(2)|kidney(6)|large_intestine(8)|lung(12)|ovary(3)|skin(6)|urinary_tract(1)	46		all_cancers(142;0.186)|Prostate(80;0.081)	KIRC - Kidney renal clear cell carcinoma(527;0.159)|Kidney(363;0.221)	OV - Ovarian serous cystadenocarcinoma(64;0.00126)|Epithelial(69;0.00238)|all cancers(49;0.00783)		GCTGGTCTCTTTGTGTGAATT	0.507	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													79	76	77	NA	NA	NA	NA	5		NA								NA			NA				124080387		2203	4300	6503	SO:0001583	missense			ENSG00000168916	HGNC:29238	XM_114432	Approved	uc003ktq.1	NA	A7E2W9|Q3SYM6|Q68D12|Q8IY05|Q9Y5A1	ENST00000306315.5	37	CCDS34219.1	.	.	.	.	.	.	.	.	.	.	T	16.61	3.170286	0.57584	.	.	ENSG00000168916	ENST00000306315;ENST00000509799;ENST00000513986	T	0.49432	0.78	5.34	5.34	0.76211	.	0.000000	0.64402	D	0.000003	T	0.53110	0.1776	L	0.51422	1.61	0.40151	D	0.976947	D	0.56968	0.978	P	0.50659	0.647	T	0.57653	-0.7774	10	0.54805	T	0.06	-16.0979	15.3023	0.73962	0.0:0.0:0.0:1.0	.	99	Q9ULD9	ZN608_HUMAN	T	99	ENSP00000307746:K99T	ENSP00000307746:K99T	K	-	2	0	ZNF608	124108286	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	6.003000	0.70701	2.158000	0.67659	0.533000	0.62120	AAA	ZNF608-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000371300.1	241.653286	KEEP		-	241.654864	0.496241	66	67	---	---	---	---	1	0.9965084	7	5	0	147	72	69	0	147	2	0	0	0	0	0	0	72	69	0	147	2	TP
PCDHA1	0	broad.mit.edu	37	5	140166327	140166327	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr5:140166327G>A	ENST00000504120.2	+	1	452	c.452G>A	c.(451-453)cGt>cAt	p.R151H	PCDHA1_ENST00000394633.3_Missense_Mutation_p.R151H|PCDHA1_ENST00000378133.3_Missense_Mutation_p.R151H	NM_018900.2	NP_061723.1				NA		NA		NA						breast(3)|endometrium(3)|kidney(2)|large_intestine(13)|lung(34)|prostate(3)|skin(4)|upper_aerodigestive_tract(5)|urinary_tract(3)	70			KIRC - Kidney renal clear cell carcinoma(527;0.00112)|Kidney(363;0.00191)			CTGAATTCGCGTTTTCCGATA	0.448	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													87	97	94	NA	NA	NA	NA	5		NA								NA			NA				140166327		2203	4300	6503	SO:0001583	missense								NA		ENST00000504120.2	37	CCDS54913.1	.	.	.	.	.	.	.	.	.	.	g	12.44	1.939752	0.34189	.	.	ENSG00000204970	ENST00000504120;ENST00000394633;ENST00000378133	T;T;T	0.52983	0.64;0.64;0.64	4.13	2.16	0.27623	Cadherin (2);Cadherin-like (1);	0.814614	0.10017	N	0.726395	T	0.43122	0.1233	M	0.80183	2.485	0.09310	N	1	B;P;B	0.36753	0.146;0.568;0.414	B;B;B	0.31614	0.052;0.133;0.049	T	0.48305	-0.9047	10	0.54805	T	0.06	.	2.6662	0.05051	0.1722:0.1434:0.5374:0.147	.	151;151;151	Q9Y5I3;Q9Y5I3-2;Q9Y5I3-3	PCDA1_HUMAN;.;.	H	151	ENSP00000420840:R151H;ENSP00000378129:R151H;ENSP00000367373:R151H	ENSP00000367373:R151H	R	+	2	0	PCDHA1	140146511	0.000000	0.05858	0.046000	0.18839	0.913000	0.54294	0.458000	0.21892	0.857000	0.35407	0.650000	0.86243	CGT	PCDHA1-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000389127.1	322.823819	KEEP		+	323.430329	0.449057	119	146	---	---	---	---	1	0.7015499	4	1	0	300	133	181	0	300	2	0	0	0	0	0	0	133	181	0	300	2	TP
MYLIP	29116	broad.mit.edu	37	6	16141881	16141881	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr6:16141881G>C	ENST00000356840.3	+	3	502	c.304G>C	c.(304-306)Gag>Cag	p.E102Q	MYLIP_ENST00000349606.4_5'UTR|MIR4639_ENST00000584938.1_RNA	NM_013262.3	NP_037394.2	Q8WY64	MYLIP_HUMAN	myosin regulatory light chain interacting protein	102	FERM.	NA		NA	cellular component movement|nervous system development	cytoplasm|cytoskeleton|extrinsic to membrane	cytoskeletal protein binding|ubiquitin-protein ligase activity|zinc ion binding			breast(1)|central_nervous_system(2)|endometrium(2)|kidney(1)|large_intestine(3)|lung(13)|ovary(1)|pancreas(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)	28	Breast(50;0.0799)|Ovarian(93;0.103)	all_hematologic(90;0.0895)	Epithelial(50;0.241)			GCACATCAAGGAGGCCCTCTT	0.512	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													86	83	84	NA	NA	NA	NA	6		NA								NA			NA				16141881		2203	4300	6503	SO:0001583	missense			ENSG00000007944	HGNC:21155	NM_013262	Approved	uc003nbq.3	NA	Q5TIA4|Q9BU73|Q9NRL9|Q9UHE7	ENST00000356840.3	37	CCDS4536.1	.	.	.	.	.	.	.	.	.	.	G	16.16	3.045020	0.55110	.	.	ENSG00000007944	ENST00000356840	T	0.78364	-1.17	5.33	5.33	0.75918	Band 4.1 domain (1);FERM central domain (2);FERM domain (1);FERM/acyl-CoA-binding protein, 3-helical bundle (1);	0.000000	0.85682	D	0.000000	T	0.72285	0.3441	L	0.28400	0.85	0.80722	D	1	D	0.69078	0.997	D	0.81914	0.995	T	0.69079	-0.5240	10	0.02654	T	1	.	19.037	0.92983	0.0:0.0:1.0:0.0	.	102	Q8WY64	MYLIP_HUMAN	Q	102	ENSP00000349298:E102Q	ENSP00000349298:E102Q	E	+	1	0	MYLIP	16249860	1.000000	0.71417	1.000000	0.80357	0.995000	0.86356	9.413000	0.97351	2.504000	0.84457	0.563000	0.77884	GAG	MYLIP-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000043864.1	244.618419	KEEP		+	245.227301	0.433962	69	90	---	---	---	---	1	0.9998829	12	12	0	181	80	116	0	181	2	0	0	0	0	0	0	80	116	0	181	2	TP
SLC26A3	1811	broad.mit.edu	37	7	107416977	107416977	+	Missense_Mutation	SNP	C	C	G			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr7:107416977C>G	ENST00000340010.5	-	15	1781	c.1597G>C	c.(1597-1599)Gaa>Caa	p.E533Q	SLC26A3_ENST00000422236.2_Missense_Mutation_p.E498Q	NM_000111.2	NP_000102.1	P40879	S26A3_HUMAN	solute carrier family 26 (anion exchanger), member 3	533	STAS.	NA		NA	excretion	integral to membrane|membrane fraction	inorganic anion exchanger activity|secondary active sulfate transmembrane transporter activity|sequence-specific DNA binding transcription factor activity|transcription cofactor activity	p.E533K(1)		breast(1)|central_nervous_system(3)|cervix(1)|endometrium(3)|kidney(1)|large_intestine(4)|lung(18)|ovary(4)|prostate(1)|skin(6)|upper_aerodigestive_tract(3)|urinary_tract(1)	46						TTCACTCCTTCTGGCTCATAC	0.378	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - Missense(1)	lung(1)											115	108	111	NA	NA	NA	NA	7		NA								NA			NA				107416977		2203	4300	6503	SO:0001583	missense			ENSG00000091138	HGNC:3018	NM_000111	Approved	uc003ver.2	NA		ENST00000340010.5	37	CCDS5748.1	.	.	.	.	.	.	.	.	.	.	C	4.567	0.105228	0.08731	.	.	ENSG00000091138	ENST00000422236;ENST00000340010	D;D	0.94232	-3.38;-3.38	5.82	4.93	0.64822	Sulphate transporter/antisigma-factor antagonist STAS (4);	0.397106	0.29948	N	0.010784	D	0.90195	0.6935	L	0.42245	1.32	0.44168	D	0.996978	B;B	0.26445	0.121;0.149	B;B	0.28553	0.047;0.091	D	0.85357	0.1105	10	0.36615	T	0.2	.	13.2746	0.60180	0.0:0.8209:0.1142:0.0649	.	498;533	G5E9U3;P40879	.;S26A3_HUMAN	Q	498;533	ENSP00000415817:E498Q;ENSP00000345873:E533Q	ENSP00000345873:E533Q	E	-	1	0	SLC26A3	107204213	0.993000	0.37304	0.710000	0.30468	0.048000	0.14542	2.976000	0.49289	0.827000	0.34685	-1.094000	0.02160	GAA	SLC26A3-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000337190.1	-29.409517	KEEP		-	6.438993	0.021429	3	137	---	---	---	---	0	0	0	0	0	134	3	146	0	134	2	1	0.9908418	8	532	0	631	3	146	0	134	2	TP
KCNK9	51305	broad.mit.edu	37	8	140630517	140630517	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr8:140630517C>T	ENST00000520439.1	-	2	1172	c.1109G>A	c.(1108-1110)cGc>cAc	p.R370H	KCNK9_ENST00000303015.1_Missense_Mutation_p.R370H|KCNK9_ENST00000523477.1_5'Flank			Q9NPC2	KCNK9_HUMAN	potassium channel, subfamily K, member 9	370		NA		NA		integral to membrane|membrane fraction	potassium channel activity|voltage-gated ion channel activity			NS(1)|endometrium(9)|kidney(1)|large_intestine(9)|lung(17)|ovary(2)|prostate(3)|skin(1)	43	all_cancers(97;3.94e-14)|all_epithelial(106;4.81e-13)|Lung NSC(106;8.18e-05)|all_lung(105;0.00015)|Ovarian(258;0.00235)|Acute lymphoblastic leukemia(118;0.155)	Ovarian(118;0.134)	BRCA - Breast invasive adenocarcinoma(115;0.0855)			GGACTTCCGGCGTTTCATCAG	0.453	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													118	114	115	NA	NA	NA	NA	8		NA								NA			NA				140630517		2203	4300	6503	SO:0001583	missense			ENSG00000169427	HGNC:6283	NM_016601	Approved	uc003yvf.1	NA	Q2M290|Q540F2	ENST00000520439.1	37	CCDS6377.1	.	.	.	.	.	.	.	.	.	.	C	14.39	2.520749	0.44866	.	.	ENSG00000169427	ENST00000522317;ENST00000303015;ENST00000520439	T;T;T	0.35789	1.29;1.29;1.29	5.19	5.19	0.71726	.	0.000000	0.85682	D	0.000000	T	0.59183	0.2175	M	0.75264	2.295	0.33991	D	0.649134	D	0.89917	1.0	D	0.91635	0.999	T	0.71652	-0.4528	10	0.87932	D	0	.	12.9203	0.58228	0.162:0.838:0.0:0.0	.	370	Q9NPC2	KCNK9_HUMAN	H	370	ENSP00000429847:R370H;ENSP00000302166:R370H;ENSP00000430676:R370H	ENSP00000302166:R370H	R	-	2	0	KCNK9	140699699	0.925000	0.31364	0.046000	0.18839	0.317000	0.28152	7.093000	0.76937	2.684000	0.91462	0.563000	0.77884	CGC	KCNK9-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000378473.1	265.999041	KEEP		-	266.13035	0.472637	95	106	---	---	---	---	1	0.9895855	11	0	0	261	113	125	0	261	2	0	0	0	0	0	0	113	125	0	261	2	TP
PLEC	5339	broad.mit.edu	37	8	144992145	144992145	+	Silent	SNP	C	C	T			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr8:144992145C>T	ENST00000322810.4	-	32	12424	c.12255G>A	c.(12253-12255)tcG>tcA	p.S4085S	PLEC_ENST00000354589.3_Silent_p.S3948S|PLEC_ENST00000357649.2_Silent_p.S3952S|PLEC_ENST00000356346.3_Silent_p.S3934S|PLEC_ENST00000527096.1_Silent_p.S3971S|PLEC_ENST00000354958.2_Silent_p.S3926S|PLEC_ENST00000398774.2_Silent_p.S3916S|PLEC_ENST00000345136.3_Silent_p.S3948S|PLEC_ENST00000436759.2_Silent_p.S3975S	NM_201380.2	NP_958782.1	Q15149	PLEC_HUMAN	plectin	4085	Globular 2.	NA		NA	cellular component disassembly involved in apoptosis|hemidesmosome assembly	cytosol|focal adhesion|hemidesmosome|intermediate filament cytoskeleton|sarcolemma	actin binding|structural constituent of muscle			NS(1)|breast(3)|central_nervous_system(4)|cervix(7)|endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|kidney(9)|large_intestine(8)|lung(57)|ovary(4)|pancreas(2)|prostate(11)|skin(9)|stomach(2)|upper_aerodigestive_tract(10)	137						CCTGGTACACCGAGAGCCGTT	0.612	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													26	31	29	NA	NA	NA	NA	8		NA								NA			NA				144992145		2111	4222	6333	SO:0001819	synonymous_variant			ENSG00000178209	HGNC:9069	NM_000445	Approved	uc003zaf.1	NA	Q15148|Q16640|Q6S376|Q6S377|Q6S378|Q6S379|Q6S380|Q6S381|Q6S382|Q6S383	ENST00000322810.4	37	CCDS43772.1																																																																																			PLEC-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000383281.1	39.214542	KEEP		-	40.57742	0.319149	15	32	---	---	---	---	1	1	69	80	0	91	16	33	0	91	2	0	0	0	0	0	0	16	33	0	91	2	TP
DCAF12	25853	broad.mit.edu	37	9	34088336	34088336	+	3'UTR	SNP	G	G	T			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr9:34088336G>T	ENST00000361264.4	-	0	1715				RP11-537H15.3_ENST00000448245.1_RNA	NM_015397.3	NP_056212.1	Q5T6F0	DCA12_HUMAN	DDB1 and CUL4 associated factor 12	NA		NA		NA		centrosome|CUL4 RING ubiquitin ligase complex				breast(1)|endometrium(2)|kidney(1)|large_intestine(2)|lung(4)|prostate(1)	11						CTCTGCATTTGGGGAGTTGTC	0.448	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													109	110	109	NA	NA	NA	NA	9		NA								NA			NA				34088336		2203	4300	6503	SO:0001624	3_prime_UTR_variant			ENSG00000198876	HGNC:19911	NM_015397	Approved	uc003ztt.2	NA	A8KA70|D3DRL6|Q5T6E9|Q5T6F1|Q6P3V0|Q7L4F8|Q96PZ5|Q9NXA9|Q9UFJ1	ENST00000361264.4	37	CCDS6549.1																																																																																			DCAF12-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000052133.2	-74.022252	KEEP		-	6.740042	0.016393	5	300	---	---	---	---	1	0.6624365	2	137	0	259	5	328	0	259	2	0	0	0	0	0	0	5	328	0	259	2	TP
MAMDC4	158056	broad.mit.edu	37	9	139755072	139755072	+	3'UTR	SNP	C	C	T			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr9:139755072C>T	ENST00000445819.1	+	0	3718				MAMDC4_ENST00000485732.1_3'UTR|MAMDC4_ENST00000317446.2_3'UTR			Q6UXC1	AEGP_HUMAN	MAM domain containing 4	NA		NA		NA	protein transport	integral to membrane				breast(4)|central_nervous_system(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(2)|kidney(1)|large_intestine(1)|lung(4)|pancreas(1)|prostate(2)|upper_aerodigestive_tract(2)	19	all_cancers(76;0.0763)|all_epithelial(76;0.198)	Myeloproliferative disorder(178;0.0511)		OV - Ovarian serous cystadenocarcinoma(145;1.52e-05)|Epithelial(140;0.000171)		CCAGACAAGGCCCCGCTTCCT	0.587	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													82	68	72	NA	NA	NA	NA	9		NA								NA			NA				139755072		2203	4300	6503	SO:0001624	3_prime_UTR_variant			ENSG00000177943	HGNC:24083	NM_206920	Approved	uc004cjs.3	NA	A2A3D4|B0QZ81|Q5T5S2|Q8NCX7	ENST00000445819.1	37																																																																																				MAMDC4-201	KNOWN	basic	protein_coding	NA	protein_coding		60.015286	KEEP		+	61.583341	0.338235	23	45	---	---	---	---	1	0.9973616	6	14	0	91	30	51	0	91	2	0	0	0	0	0	0	30	51	0	91	2	TP
PTEN	5728	broad.mit.edu	37	10	89653826	89653826	+	Missense_Mutation	SNP	C	C	G			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr10:89653826C>G	ENST00000371953.3	+	2	1481	c.124C>G	c.(124-126)Ctt>Gtt	p.L42V		NM_000314.4	NP_000305.3	P60484	PTEN_HUMAN	phosphatase and tensin homolog	42	Phosphatase tensin-type.	NA	L -> R (in glioma; retains phosphatase activity towards Ins(1,3,4,5)P4 and PtdIns(3,4,5)P3; retains the ability to bind phospholipid membranes).	NA	activation of mitotic anaphase-promoting complex activity|apoptosis|canonical Wnt receptor signaling pathway|cell proliferation|central nervous system development|induction of apoptosis|inositol phosphate dephosphorylation|negative regulation of cell migration|negative regulation of cyclin-dependent protein kinase activity involved in G1/S|negative regulation of focal adhesion assembly|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of protein kinase B signaling cascade|negative regulation of protein phosphorylation|nerve growth factor receptor signaling pathway|phosphatidylinositol dephosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of sequence-specific DNA binding transcription factor activity|protein stabilization|regulation of neuron projection development|T cell receptor signaling pathway	cytosol|internal side of plasma membrane|PML body	anaphase-promoting complex binding|enzyme binding|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity|lipid binding|magnesium ion binding|PDZ domain binding|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity|phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity	p.0?(37)|p.?(8)|p.Y27fs*1(2)		NS(28)|autonomic_ganglia(2)|biliary_tract(6)|bone(5)|breast(92)|central_nervous_system(676)|cervix(26)|endometrium(1068)|eye(8)|haematopoietic_and_lymphoid_tissue(137)|kidney(24)|large_intestine(98)|liver(20)|lung(91)|meninges(2)|oesophagus(2)|ovary(82)|pancreas(6)|prostate(129)|salivary_gland(5)|skin(127)|soft_tissue(19)|stomach(30)|testis(1)|thyroid(29)|upper_aerodigestive_tract(29)|urinary_tract(12)|vulva(17)	2771		all_cancers(4;3.61e-31)|all_epithelial(4;3.96e-23)|Prostate(4;8.12e-23)|Breast(4;0.000111)|Melanoma(5;0.00146)|all_hematologic(4;0.00227)|Colorectal(252;0.00494)|all_neural(4;0.00513)|Acute lymphoblastic leukemia(4;0.0116)|Glioma(4;0.0274)|all_lung(38;0.132)	KIRC - Kidney renal clear cell carcinoma(1;0.214)	UCEC - Uterine corpus endometrioid carcinoma (6;0.000228)|all cancers(1;4.16e-84)|GBM - Glioblastoma multiforme(1;7.77e-49)|Epithelial(1;7.67e-41)|OV - Ovarian serous cystadenocarcinoma(1;6.22e-15)|BRCA - Breast invasive adenocarcinoma(1;1.1e-06)|Lung(2;3.18e-06)|Colorectal(12;4.88e-06)|LUSC - Lung squamous cell carcinoma(2;4.97e-06)|COAD - Colon adenocarcinoma(12;1.13e-05)|Kidney(1;0.000288)|KIRC - Kidney renal clear cell carcinoma(1;0.00037)|STAD - Stomach adenocarcinoma(243;0.218)		TGCAGAAAGACTTGAAGGCGT	0.294	NA	31	"""D, Mis, N, F, S"""		"""glioma,  prostate, endometrial"""	"""harmartoma, glioma,  prostate, endometrial"""	NA		Proteus syndrome;Juvenile Polyposis;Hereditary Mixed Polyposis Syndrome type 1;Cowden syndrome;Bannayan-Riley-Ruvalcaba syndrome	HNSCC(9;0.0022)|TCGA GBM(2;<1E-08)|TSP Lung(26;0.18)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	"""Cowden Syndrome, Bannayan-Riley-Ruvalcaba syndrome"""	10	10q23.3	5728	phosphatase and tensin homolog gene	NA	"""L, E, M, O"""	47	Whole gene deletion(37)|Unknown(8)|Deletion - Frameshift(2)	prostate(14)|central_nervous_system(8)|skin(8)|haematopoietic_and_lymphoid_tissue(4)|lung(4)|ovary(3)|breast(2)|soft_tissue(1)|urinary_tract(1)|NS(1)|kidney(1)											112	113	113	NA	NA	NA	NA	10		NA								NA			NA				89653826		2203	4295	6498	SO:0001583	missense	Familial Cancer Database	Incl.: Encephalocraniocutaneous Lipomatosis, ECCL, Proteus-like s.;incl.: Juvenile Polyposis of the Stomach;HMPS1, Colorectal Adenoma Carcinoma syndrome, CRAC, CRAC1;CS, Cowden disease, Multiple Hamartoma Syndrome, incl.: Lhermitte-Duclos; part of PTEN hamartoma tumour syndrome (PHTS) / PTEN-MATCHS, Cowden-like syndrome;subset of PTEN-Hamartoma Tumor Syndrome; incl.: Ruvalcaba-Myhre-Smith s.	ENSG00000171862	HGNC:9588	NM_000314	Approved	uc001kfb.3	NA	B2R904|O00633|O02679|Q6ICT7	ENST00000371953.3	37	CCDS31238.1	.	.	.	.	.	.	.	.	.	.	C	23.7	4.452838	0.84209	.	.	ENSG00000171862	ENST00000371953	D	0.98617	-5.03	5.19	5.19	0.71726	Phosphatase tensin type (1);	0.000000	0.85682	D	0.000000	D	0.96163	0.8749	L	0.39245	1.2	0.80722	D	1	P	0.38020	0.615	B	0.29267	0.1	D	0.96059	0.9037	9	.	.	.	-8.6179	17.4682	0.87639	0.0:1.0:0.0:0.0	.	42	P60484	PTEN_HUMAN	V	42	ENSP00000361021:L42V	.	L	+	1	0	PTEN	89643806	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	5.453000	0.66645	2.421000	0.82119	0.655000	0.94253	CTT	PTEN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000049241.1	311.097606	KEEP		+	314.95413	0.696429	78	34	---	---	---	---	1	1	29	16	0	224	88	38	0	224	2	1	1	181	211	0	394	88	38	0	224	2	TP
GDPD5	81544	broad.mit.edu	37	11	75160035	75160035	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr11:75160035C>T	ENST00000526177.1	-	5	2165	c.287G>A	c.(286-288)cGc>cAc	p.R96H	GDPD5_ENST00000443276.2_3'UTR|GDPD5_ENST00000529721.1_Missense_Mutation_p.R234H|GDPD5_ENST00000533805.1_5'UTR|GDPD5_ENST00000376282.3_Missense_Mutation_p.R115H|GDPD5_ENST00000533784.1_Missense_Mutation_p.R115H|GDPD5_ENST00000336898.3_Missense_Mutation_p.R234H			Q8WTR4	GDPD5_HUMAN	glycerophosphodiester phosphodiesterase domain containing 5	234		NA		NA	glycerol metabolic process|lipid metabolic process|nervous system development	endomembrane system|growth cone|integral to membrane|perinuclear region of cytoplasm	glycerophosphodiester phosphodiesterase activity	p.R234H(1)		breast(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(2)|kidney(1)|large_intestine(3)|lung(6)|ovary(3)|skin(2)	20						GGGGGCCCCGCGGTGGCCAAT	0.607	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - Missense(1)	lung(1)											46	48	48	NA	NA	NA	NA	11		NA								NA			NA				75160035		2200	4293	6493	SO:0001583	missense				HGNC:28804	NM_030792	Approved	uc001owp.4	NA	Q49AQ5|Q6UX76|Q7Z4S0|Q8N781|Q8NCB7|Q8TB77	ENST00000526177.1	37		.	.	.	.	.	.	.	.	.	.	C	29.9	5.041352	0.93685	.	.	ENSG00000158555	ENST00000526177;ENST00000533784;ENST00000529721;ENST00000336898;ENST00000376282	T;T;T;T;T	0.54866	0.55;0.55;0.55;0.55;0.55	5.27	5.27	0.74061	PLC-like phosphodiesterase, TIM beta/alpha-barrel domain (2);	0.055956	0.64402	D	0.000001	D	0.82595	0.5071	H	0.97783	4.075	0.80722	D	1	D;D;D	0.89917	1.0;1.0;1.0	D;D;D	0.75020	0.985;0.97;0.985	D	0.88730	0.3236	10	0.87932	D	0	-28.3253	16.4369	0.83878	0.0:1.0:0.0:0.0	.	96;115;234	Q8WTR4-3;Q8WTR4-2;Q8WTR4	.;.;GDPD5_HUMAN	H	96;115;234;234;115	ENSP00000434050:R96H;ENSP00000437049:R115H;ENSP00000433214:R234H;ENSP00000337972:R234H;ENSP00000365459:R115H	ENSP00000337972:R234H	R	-	2	0	GDPD5	74837683	1.000000	0.71417	0.966000	0.40874	0.880000	0.50808	5.303000	0.65738	2.758000	0.94735	0.561000	0.74099	CGC	GDPD5-007	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000384405.1	83.873765	KEEP		-	83.877601	0.508772	29	28	---	---	---	---	1	0.9952158	7	5	0	99	37	36	0	99	2	0	0	0	0	0	0	37	36	0	99	2	TP
USP35	57558	broad.mit.edu	37	11	77920718	77920718	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr11:77920718G>A	ENST00000529308.1	+	10	2078	c.1817G>A	c.(1816-1818)tGt>tAt	p.C606Y	USP35_ENST00000530535.1_3'UTR|USP35_ENST00000530267.1_Missense_Mutation_p.C174Y|USP35_ENST00000526425.1_Missense_Mutation_p.C337Y|USP35_ENST00000441408.2_Missense_Mutation_p.C192Y	NM_020798.2	NP_065849.1	Q9P2H5	UBP35_HUMAN	ubiquitin specific peptidase 35	606		NA		NA	ubiquitin-dependent protein catabolic process		binding|cysteine-type peptidase activity|ubiquitin thiolesterase activity			endometrium(6)|kidney(1)|large_intestine(2)|lung(8)|ovary(2)|prostate(3)|urinary_tract(1)	23	all_cancers(14;3.77e-18)|all_epithelial(13;6.16e-21)|Breast(9;5.6e-16)|Ovarian(111;0.152)		OV - Ovarian serous cystadenocarcinoma(8;1.04e-25)			CCTGAGCGCTGTCGCCGCCGC	0.657	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													47	53	51	NA	NA	NA	NA	11		NA								NA			NA				77920718		2020	4151	6171	SO:0001583	missense				HGNC:20061	XM_290527	Approved	uc021qny.1	NA		ENST00000529308.1	37	CCDS41693.1	.	.	.	.	.	.	.	.	.	.	g	3.089	-0.187367	0.06299	.	.	ENSG00000118369	ENST00000530267;ENST00000529308;ENST00000441408;ENST00000526425	T;T;T;T	0.12255	3.22;3.47;2.7;3.36	4.89	3.03	0.35002	Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2 (2);	0.705821	0.12300	N	0.481191	T	0.07863	0.0197	N	0.22421	0.69	0.20489	N	0.999899	B;B	0.06786	0.001;0.001	B;B	0.06405	0.001;0.002	T	0.42327	-0.9458	10	0.15499	T	0.54	-3.3421	5.1508	0.15009	0.2466:0.1515:0.6018:0.0	.	606;192	Q9P2H5;E7EWV7	UBP35_HUMAN;.	Y	174;606;192;337	ENSP00000435468:C174Y;ENSP00000431876:C606Y;ENSP00000400825:C192Y;ENSP00000434942:C337Y	ENSP00000400825:C192Y	C	+	2	0	USP35	77598366	0.996000	0.38824	0.774000	0.31636	0.849000	0.48306	2.029000	0.41098	0.661000	0.30985	0.586000	0.80456	TGT	USP35-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000390026.1	94.375107	KEEP		+	100.288924	0.287671	42	104	---	---	---	---	1	0.9039827	3	11	1	186	45	128	1	186	2	0	0	0	0	0	0	45	128	1	186	2	TP
HEPHL1	341208	broad.mit.edu	37	11	93803618	93803618	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr11:93803618G>A	ENST00000315765.9	+	6	1150	c.1142G>A	c.(1141-1143)cGc>cAc	p.R381H		NM_001098672.1	NP_001092142.1	Q6MZM0	HPHL1_HUMAN	hephaestin-like 1	381	Plastocyanin-like 3.	NA	R -> C (in dbSNP:rs12291622).	NA	copper ion transport	integral to membrane	copper ion binding|oxidoreductase activity			NS(2)|breast(4)|central_nervous_system(1)|endometrium(5)|kidney(2)|large_intestine(11)|lung(25)|ovary(3)|prostate(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(3)	61		Acute lymphoblastic leukemia(157;2.34e-05)|all_hematologic(158;0.00824)				CAACAGAGGCGCTACTTTATA	0.443	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0								G	HIS/ARG	0,3690		0,0,1845	52	48	49	NA	1142	-0.3	0.7	11		49	4,8174		0,4,4085	yes	missense	HEPHL1	NM_001098672.1	29	0,4,5930	AA,AG,GG	NA	0.0489,0.0,0.0337	benign	381/1160	93803618	4,11864	1845	4089	5934	SO:0001583	missense			ENSG00000181333	HGNC:30477	XM_291947	Approved	uc001pep.2	NA	Q3C1W7	ENST00000315765.9	37	CCDS44710.1	.	.	.	.	.	.	.	.	.	.	G	1.879	-0.458357	0.04508	0.0	4.89E-4	ENSG00000181333	ENST00000315765	D	0.98876	-5.2	5.7	-0.323	0.12709	Cupredoxin (2);	0.680056	0.16003	N	0.234209	D	0.94221	0.8145	N	0.13299	0.325	0.09310	N	1	B	0.02656	0.0	B	0.04013	0.001	D	0.86739	0.1953	10	0.25106	T	0.35	.	10.4347	0.44428	0.3591:0.0:0.6409:0.0	.	381	Q6MZM0	HPHL1_HUMAN	H	381	ENSP00000313699:R381H	ENSP00000313699:R381H	R	+	2	0	HEPHL1	93443266	0.000000	0.05858	0.737000	0.30932	0.849000	0.48306	-0.778000	0.04664	-0.352000	0.08237	0.650000	0.86243	CGC	HEPHL1-001	KNOWN	not_organism_supported|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000396103.2	42.01934	KEEP		+	42.078894	0.454545	15	18	---	---	---	---	1	0.2064777	2	0	0	50	16	20	0	50	2	0	0	0	0	0	0	16	20	0	50	2	TP
C11orf70	85016	broad.mit.edu	37	11	101952014	101952014	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr11:101952014T>C	ENST00000526781.1	+	6	693	c.677T>C	c.(676-678)gTa>gCa	p.V226A	C11orf70_ENST00000434758.2_Splice_Site			Q9BRQ4	CK070_HUMAN	chromosome 11 open reading frame 70	226		NA		NA						breast(1)|kidney(1)|lung(5)|ovary(1)|prostate(2)|skin(2)	12	all_epithelial(12;0.0137)	Acute lymphoblastic leukemia(157;0.000966)|all_hematologic(158;0.0137)	Lung(13;0.245)	BRCA - Breast invasive adenocarcinoma(274;0.0335)		TCAGCTTATGTAAGTGTGAGA	0.318	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													80	80	80	NA	NA	NA	NA	11		NA								NA			NA				101952014		2203	4294	6497	SO:0001583	missense			ENSG00000137691	HGNC:28188	NM_032930	Approved	uc001pgp.3	NA		ENST00000526781.1	37		.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	T|T	22.6|22.6	4.305363|4.305363	0.81247|0.81247	.|.	.|.	ENSG00000137691|ENSG00000137691	ENST00000434758;ENST00000423732|ENST00000526781	.|.	.|.	.|.	5.63|5.63	5.63|5.63	0.86233|0.86233	.|.	.|.	.|.	.|.	.|.	.|T	.|0.71281	.|0.3321	.|.	.|.	.|.	0.80722|0.80722	D|D	1|1	.|.	.|.	.|.	.|.	.|.	.|.	.|T	.|0.70436	.|-0.4872	.|4	.|.	.|.	.|.	.|.	14.9526|14.9526	0.71086|0.71086	0.0:0.0:0.0:1.0|0.0:0.0:0.0:1.0	.|.	.|.	.|.	.|.	.|A	-1|226	.|.	.|.	.|V	+|+	.|2	.|0	C11orf70|C11orf70	101457224|101457224	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.975000|0.975000	0.68041|0.68041	6.290000|6.290000	0.72712|0.72712	2.270000|2.270000	0.75569|0.75569	0.460000|0.460000	0.39030|0.39030	.|GTA	C11orf70-004	PUTATIVE	basic	protein_coding	NA	protein_coding	OTTHUMT00000394145.1	80.50051	KEEP		+	88.039645	0.230088	26	87	---	---	---	---	1	0.06	2	0	0	174	29	93	0	174	2	0	0	0	0	0	0	29	93	0	174	2	TP
SOX5	6660	broad.mit.edu	37	12	24048786	24048786	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr12:24048786A>G	ENST00000546136.1	-	1	174	c.172T>C	c.(172-174)Tct>Cct	p.S58P	SOX5_ENST00000537393.1_Intron|SOX5_ENST00000309359.1_Missense_Mutation_p.S58P|SOX5_ENST00000451604.2_Missense_Mutation_p.S71P|SOX5_ENST00000541847.1_Missense_Mutation_p.S61P|SOX5_ENST00000541536.1_Missense_Mutation_p.S58P|SOX5_ENST00000441133.2_Intron|SOX5_ENST00000381381.2_Missense_Mutation_p.S58P|SOX5_ENST00000545921.1_Missense_Mutation_p.S61P			P35711	SOX5_HUMAN	SRY (sex determining region Y)-box 5	71		NA		NA	transcription from RNA polymerase II promoter	nucleus	DNA binding|protein binding|sequence-specific DNA binding transcription factor activity			NS(1)|breast(3)|central_nervous_system(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(10)|lung(25)|ovary(5)|skin(2)|upper_aerodigestive_tract(3)	57						GTCAGCAGAGAAACTGGCTGA	0.483	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													232	225	227	NA	NA	NA	NA	12		NA								NA			NA				24048786		2203	4300	6503	SO:0001583	missense			ENSG00000134532	HGNC:11201	NM_006940	Approved	uc001rfw.3	NA	Q86UK8|Q8J017|Q8J018|Q8J019|Q8J020|Q8N1D9|Q8N7E0|Q8TEA4	ENST00000546136.1	37	CCDS44844.1	.	.	.	.	.	.	.	.	.	.	A	12.94	2.089730	0.36855	.	.	ENSG00000134532	ENST00000546136;ENST00000309359;ENST00000381381;ENST00000451604;ENST00000541536;ENST00000545921;ENST00000541847;ENST00000538083	D;D;D;D;D;D	0.97480	-4.37;-4.37;-4.4;-4.37;-4.4;-4.37	5.79	4.65	0.58169	.	0.221307	0.42053	D	0.000775	D	0.96084	0.8724	M	0.74258	2.255	0.42680	D	0.993543	B;P	0.37330	0.0;0.59	B;B	0.39971	0.0;0.315	D	0.94232	0.7477	10	0.34782	T	0.22	.	11.5995	0.50995	0.9307:0.0:0.0693:0.0	.	58;71	P35711-4;P35711	.;SOX5_HUMAN	P	58;58;58;71;58;61;61;58	ENSP00000437487:S58P;ENSP00000308927:S58P;ENSP00000370788:S58P;ENSP00000398273:S71P;ENSP00000441973:S58P;ENSP00000443520:S61P	ENSP00000308927:S58P	S	-	1	0	SOX5	23940053	1.000000	0.71417	1.000000	0.80357	0.962000	0.63368	3.863000	0.56016	1.031000	0.39867	0.528000	0.53228	TCT	SOX5-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000402005.2	861.776062	KEEP		-	861.895958	0.517094	242	226	---	---	---	---	1	0.991471	9	1	0	594	286	267	0	594	2	0	0	0	0	0	0	286	267	0	594	2	TP
ADCY6	112	broad.mit.edu	37	12	49177053	49177053	+	Silent	SNP	G	G	T			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr12:49177053G>T	ENST00000307885.4	-	1	859	c.165C>A	c.(163-165)ccC>ccA	p.P55P	ADCY6_ENST00000357869.3_Silent_p.P55P|ADCY6_ENST00000550422.1_Silent_p.P55P	NM_015270.3	NP_056085.1	O43306	ADCY6_HUMAN	adenylate cyclase 6	55		NA		NA	activation of adenylate cyclase activity by G-protein signaling pathway|activation of phospholipase C activity|activation of protein kinase A activity|cellular response to glucagon stimulus|energy reserve metabolic process|inhibition of adenylate cyclase activity by G-protein signaling pathway|nerve growth factor receptor signaling pathway|synaptic transmission|transmembrane transport|water transport	integral to membrane	ATP binding|metal ion binding			breast(1)|endometrium(6)|kidney(1)|large_intestine(2)|lung(16)|prostate(1)|skin(1)|urinary_tract(1)	29						CCGCAGGGGTGGGGCTGGGTG	0.726	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													12	15	14	NA	NA	NA	NA	12		NA								NA			NA				49177053		2190	4276	6466	SO:0001819	synonymous_variant				HGNC:237	NM_020983	Approved	uc001rsh.4	NA	Q9NR75|Q9UDB0	ENST00000307885.4	37	CCDS8767.1																																																																																			ADCY6-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000408863.1	35.468453	KEEP		-	35.536419	0.448276	13	16	---	---	---	---	1	0.702233	2	3	0	52	15	20	0	52	2	0	0	0	0	0	0	15	20	0	52	2	TP
ADCY6	112	broad.mit.edu	37	12	49177063	49177063	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr12:49177063G>A	ENST00000307885.4	-	1	849	c.155C>T	c.(154-156)cCa>cTa	p.P52L	ADCY6_ENST00000357869.3_Missense_Mutation_p.P52L|ADCY6_ENST00000550422.1_Missense_Mutation_p.P52L	NM_015270.3	NP_056085.1	O43306	ADCY6_HUMAN	adenylate cyclase 6	52		NA		NA	activation of adenylate cyclase activity by G-protein signaling pathway|activation of phospholipase C activity|activation of protein kinase A activity|cellular response to glucagon stimulus|energy reserve metabolic process|inhibition of adenylate cyclase activity by G-protein signaling pathway|nerve growth factor receptor signaling pathway|synaptic transmission|transmembrane transport|water transport	integral to membrane	ATP binding|metal ion binding			breast(1)|endometrium(6)|kidney(1)|large_intestine(2)|lung(16)|prostate(1)|skin(1)|urinary_tract(1)	29						GGGGCTGGGTGGCTCTGCATC	0.716	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													14	17	16	NA	NA	NA	NA	12		NA								NA			NA				49177063		2199	4294	6493	SO:0001583	missense				HGNC:237	NM_020983	Approved	uc001rsh.4	NA	Q9NR75|Q9UDB0	ENST00000307885.4	37	CCDS8767.1	.	.	.	.	.	.	.	.	.	.	G	12.52	1.961441	0.34565	.	.	ENSG00000174233	ENST00000357869;ENST00000550422;ENST00000307885	T;T;T	0.78364	-1.17;-1.17;-1.17	5.13	5.13	0.70059	.	0.192856	0.44688	D	0.000439	T	0.57829	0.2080	N	0.14661	0.345	0.48901	D	0.999726	B;B	0.06786	0.001;0.0	B;B	0.08055	0.003;0.001	T	0.53344	-0.8452	10	0.22109	T	0.4	.	7.6114	0.28133	0.1726:0.0:0.8274:0.0	.	52;52	O43306-2;O43306	.;ADCY6_HUMAN	L	52	ENSP00000350536:P52L;ENSP00000446730:P52L;ENSP00000311405:P52L	ENSP00000311405:P52L	P	-	2	0	ADCY6	47463330	1.000000	0.71417	0.999000	0.59377	0.955000	0.61496	3.832000	0.55783	2.667000	0.90743	0.561000	0.74099	CCA	ADCY6-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000408863.1	32.518154	KEEP		-	32.720878	0.407407	11	16	---	---	---	---	1	0.8040439	3	3	0	46	14	18	0	46	2	0	0	0	0	0	0	14	18	0	46	2	TP
ARL1	400	broad.mit.edu	37	12	101796696	101796696	+	Silent	SNP	C	C	T			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr12:101796696C>T	ENST00000261636.8	-	3	345	c.171G>A	c.(169-171)acG>acA	p.T57T	ARL1_ENST00000551671.1_Silent_p.T57T|ARL1_ENST00000549302.1_5'Flank|ARL1_ENST00000539055.1_Silent_p.T11T|ARL1_ENST00000536227.1_Silent_p.T40T|ARL1_ENST00000551688.1_Intron|ARL1_ENST00000551828.1_Silent_p.T40T	NM_001177.4	NP_001168.1	P40616	ARL1_HUMAN	ADP-ribosylation factor-like 1	57		NA		NA	small GTPase mediated signal transduction	Golgi membrane	enzyme activator activity|GTP binding|GTPase activity|metal ion binding|protein binding	p.T57T(1)		central_nervous_system(1)|upper_aerodigestive_tract(1)	2		Lung NSC(355;2.1e-05)|Breast(359;0.00015)|Myeloproliferative disorder(1001;0.163)		GBM - Glioblastoma multiforme(134;1.67e-09)|BRCA - Breast invasive adenocarcinoma(302;0.0125)		GGTTTTTGTACGTCACCGTCT	0.358	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - coding silent(1)	large_intestine(1)						C		1,3651		0,1,1825	139	131	134	NA	171	0.1	1	12		134	0,8172		0,0,4086	no	coding-synonymous	ARL1	NM_001177.4	NA	0,1,5911	TT,TC,CC	NA	0.0,0.0274,0.0085		57/182	101796696	1,11823	1826	4086	5912	SO:0001819	synonymous_variant				HGNC:692	NM_001177	Approved	uc001tib.3	NA	P80417|Q53XB1	ENST00000261636.8	37	CCDS44958.1																																																																																			ARL1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000408246.1	92.558361	KEEP		-	95.600473	0.324324	36	75	---	---	---	---	1	1	71	143	0	125	39	92	0	125	2	0	0	0	0	0	0	39	92	0	125	2	TP
HEATR5A	25938	broad.mit.edu	37	14	31816973	31816973	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr14:31816973C>T	ENST00000543095.2	-	19	3033	c.2849G>A	c.(2848-2850)aGc>aAc	p.S950N	HEATR5A_ENST00000439727.1_Missense_Mutation_p.S657N|HEATR5A_ENST00000389961.3_Missense_Mutation_p.S944N|HEATR5A_ENST00000404677.3_Missense_Mutation_p.S950N|HEATR5A_ENST00000439348.1_Missense_Mutation_p.S944N	NM_015473.3	NP_056288.2	Q86XA9	HTR5A_HUMAN	HEAT repeat containing 5A	944		NA		NA			binding			breast(1)|central_nervous_system(1)|endometrium(2)|kidney(3)|large_intestine(5)|lung(13)|ovary(1)	26	Hepatocellular(127;0.0877)|Breast(36;0.137)		LUAD - Lung adenocarcinoma(48;0.00292)|Lung(238;0.0164)|BRCA - Breast invasive adenocarcinoma(188;0.0797)|STAD - Stomach adenocarcinoma(7;0.173)	GBM - Glioblastoma multiforme(265;0.0059)		AGGAGAAGTGCTGTCCTGCGC	0.383	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													55	55	55	NA	NA	NA	NA	14		NA								NA			NA				31816973		1897	4121	6018	SO:0001583	missense			ENSG00000129493	HGNC:20276	NM_015473	Approved	uc001wrf.4	NA	Q68DD8|Q6P3S5|Q6P5R9|Q9H8D7|Q9NXB7|Q9P2N0|Q9UFQ3	ENST00000543095.2	37		.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	1.244|1.244	-0.620491|-0.620491	0.03636|0.03636	.|.	.|.	ENSG00000129493|ENSG00000129493	ENST00000538864|ENST00000389961;ENST00000439348;ENST00000439727;ENST00000543095;ENST00000404677	.|T;T;T;T;T	.|0.66460	.|-0.21;-0.21;-0.21;-0.21;-0.21	5.06|5.06	1.0|1.0	0.19881|0.19881	.|Armadillo-like helical (1);Armadillo-type fold (1);	.|0.395205	.|0.28796	.|N	.|0.014102	T|T	0.45357|0.45357	0.1338|0.1338	N|N	0.21194|0.21194	0.64|0.64	0.31668|0.31668	N|N	0.644722|0.644722	.|B;B;B	.|0.22211	.|0.008;0.066;0.002	.|B;B;B	.|0.23852	.|0.015;0.049;0.013	T|T	0.33929|0.33929	-0.9849|-0.9849	5|10	.|0.27082	.|T	.|0.32	.|.	5.5544|5.5544	0.17109|0.17109	0.0:0.5623:0.1294:0.3083|0.0:0.5623:0.1294:0.3083	.|.	.|950;944;944	.|B5MC49;Q86XA9-2;Q86XA9	.|.;.;HTR5A_HUMAN	T|N	578|944;944;657;950;950	.|ENSP00000374611:S944N;ENSP00000405407:S944N;ENSP00000408681:S657N;ENSP00000437968:S950N;ENSP00000384646:S950N	.|ENSP00000374611:S944N	A|S	-|-	1|2	0|0	HEATR5A|HEATR5A	30886724|30886724	0.097000|0.097000	0.21791|0.21791	0.766000|0.766000	0.31476|0.31476	0.050000|0.050000	0.14768|0.14768	0.579000|0.579000	0.23788|0.23788	-0.094000|-0.094000	0.12374|0.12374	-1.193000|-1.193000	0.01689|0.01689	GCA|AGC	HEATR5A-001	NOVEL	basic	protein_coding	NA	protein_coding	OTTHUMT00000402061.3	41.478518	KEEP		-	41.739516	0.619048	13	8	---	---	---	---	1	0.9999672	17	1	0	59	16	8	0	59	2	0	0	0	0	0	0	16	8	0	59	2	TP
KIF7	374654	broad.mit.edu	37	15	90189143	90189143	+	Missense_Mutation	SNP	G	G	A	rs150543610		GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr15:90189143G>A	ENST00000394412.3	-	8	1979	c.1903C>T	c.(1903-1905)Cgg>Tgg	p.R635W		NM_198525.2	NP_940927.2	Q2M1P5	KIF7_HUMAN	kinesin family member 7	635		NA		NA	microtubule-based movement|negative regulation of smoothened signaling pathway|positive regulation of smoothened signaling pathway	cilium	ATP binding|microtubule motor activity|protein binding			central_nervous_system(2)|cervix(1)|endometrium(2)|large_intestine(5)|lung(11)|ovary(2)|stomach(1)|urinary_tract(1)	25	Lung NSC(78;0.0237)|all_lung(78;0.0478)		BRCA - Breast invasive adenocarcinoma(143;0.128)			TGTAAGGTCCGCCTGGGCGGc	0.652	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0								G	TRP/ARG	2,4398	4.2+/-10.8	0,2,2198	76	72	73	NA	1903	-3	0	15	dbSNP_134	73	0,8598		0,0,4299	no	missense	KIF7	NM_198525.2	101	0,2,6497	AA,AG,GG	NA	0.0,0.0455,0.0154	benign	635/1344	90189143	2,12996	2200	4299	6499	SO:0001583	missense			ENSG00000166813	HGNC:30497	NM_198525	Approved	uc002bof.2	NA	Q3SXY0|Q6UXE9|Q8IW72	ENST00000394412.3	37	CCDS32325.2	.	.	.	.	.	.	.	.	.	.	g	5.928	0.355251	0.11239	4.55E-4	0.0	ENSG00000166813	ENST00000394412	T	0.72051	-0.62	3.84	-2.96	0.05547	.	1.363710	0.05123	N	0.491022	T	0.71576	0.3356	L	0.51422	1.61	0.09310	N	0.999991	D;D	0.76494	0.994;0.999	B;P	0.50082	0.432;0.63	T	0.68096	-0.5499	10	0.72032	D	0.01	.	12.0615	0.53564	0.0:0.0:0.3292:0.6708	.	122;635	B7ZKY4;Q2M1P5	.;KIF7_HUMAN	W	635	ENSP00000377934:R635W	ENSP00000377934:R635W	R	-	1	2	KIF7	87990147	0.000000	0.05858	0.028000	0.17463	0.051000	0.14879	-0.075000	0.11431	-0.676000	0.05238	-0.287000	0.09952	CGG	KIF7-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000347782.1	3.941681	KEEP		-	17.239205	0.097561	8	74	---	---	---	---	1	0.7353928	4	20	0	112	9	81	0	112	2	0	0	0	0	0	0	9	81	0	112	2	TP
MT1A	4489	broad.mit.edu	37	16	56669713	56669713	+	5'Flank	SNP	C	C	A			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr16:56669713C>A	ENST00000290705.8	+	0	0				MT1JP_ENST00000564564.1_RNA	NM_005946.2	NP_005937.2	P04731	MT1A_HUMAN	metallothionein 1A	NA		NA		NA		cytoplasm	cadmium ion binding|copper ion binding|zinc ion binding			endometrium(1)|large_intestine(1)|lung(1)	3						AGATCTCCAGCCTTACCGCGG	0.597	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													NA	NA	NA	NA	NA	NA	NA			NA								NA			NA				NA		NA	NA	NA	SO:0001631	upstream_gene_variant				HGNC:7393	NM_005946	Approved	uc002ejq.3	NA	Q86YX5	ENST00000290705.8	37	CCDS32454.1																																																																																			MT1A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000434324.1	-17.595898	KEEP		+	7.204337	0.037383	4	103	---	---	---	---	1	0.9999785	6	18	0	154	4	121	0	154	2	0	0	0	0	0	0	4	121	0	154	2	TP
TP53	7157	broad.mit.edu	37	17	7577535	7577535	+	Missense_Mutation	SNP	C	C	A	rs67185453		GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr17:7577535C>A	ENST00000420246.2	-	7	878	c.746G>T	c.(745-747)aGg>aTg	p.R249M	TP53_ENST00000413465.2_Missense_Mutation_p.R249M|TP53_ENST00000445888.2_Missense_Mutation_p.R249M|TP53_ENST00000269305.4_Missense_Mutation_p.R249M|TP53_ENST00000455263.2_Missense_Mutation_p.R249M|TP53_ENST00000359597.4_Missense_Mutation_p.R249M|TP53_ENST00000574684.1_5'Flank	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	249	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).	NA	R -> G (in sporadic cancers; somatic mutation).|R -> I (in a sporadic cancer; somatic mutation).|R -> K (in sporadic cancers; somatic mutation).|R -> M (in sporadic cancers; somatic mutation).|R -> N (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions).|R -> S (in sporadic cancers; somatic mutation; dbSNP:rs28934571).|R -> T (in sporadic cancers; somatic mutation).|R -> W (in sporadic cancers; somatic mutation).|RP -> SA (in a sporadic cancer; somatic mutation).|RP -> SS (in sporadic cancers; somatic mutation).	NA	activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.R249M(38)|p.R249K(20)|p.R249T(16)|p.0?(8)|p.?(5)|p.R249fs*96(4)|p.M246_P250delMNRRP(2)|p.R248_P250delRRP(1)|p.R249_P250delRP(1)|p.N247_R249delNRR(1)|p.N247_P250delNRRP(1)|p.R249fs*14(1)|p.R249_T256delRPILTIIT(1)|p.R249_I251delRPI(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GAGGATGGGCCTCCGGTTCAT	0.567	NA	111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	100	Substitution - Missense(74)|Whole gene deletion(8)|Deletion - In frame(8)|Deletion - Frameshift(5)|Unknown(5)	lung(22)|upper_aerodigestive_tract(12)|breast(8)|large_intestine(7)|liver(7)|stomach(6)|haematopoietic_and_lymphoid_tissue(5)|biliary_tract(5)|oesophagus(5)|skin(4)|bone(4)|central_nervous_system(3)|ovary(3)|adrenal_gland(2)|urinary_tract(2)|pancreas(2)|peritoneum(1)|soft_tissue(1)|prostate(1)											154	113	127	NA	NA	NA	NA	17		NA								NA			NA				7577535		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	C	22.4	4.284101	0.80803	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000509690	D;D;D;D;D;D;D	0.99869	-7.33;-7.33;-7.33;-7.33;-7.33;-7.33;-7.33	4.62	3.64	0.41730	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99871	0.9939	M	0.92367	3.3	0.52501	D	0.999959	P;D;P;P;D	0.89917	0.932;1.0;0.945;0.86;1.0	P;D;P;P;D	0.87578	0.622;0.998;0.795;0.453;0.991	D	0.96551	0.9408	10	0.87932	D	0	-3.0658	12.8645	0.57932	0.0:0.8349:0.1651:0.0	.	249;249;249;249;249	P04637-2;P04637-3;P04637;Q1MSW8;E7EQX7	.;.;P53_HUMAN;.;.	M	249;249;249;249;249;249;238;117	ENSP00000410739:R249M;ENSP00000352610:R249M;ENSP00000269305:R249M;ENSP00000398846:R249M;ENSP00000391127:R249M;ENSP00000391478:R249M;ENSP00000425104:R117M	ENSP00000269305:R249M	R	-	2	0	TP53	7518260	0.835000	0.29415	0.998000	0.56505	0.801000	0.45260	7.609000	0.82925	1.295000	0.44724	0.462000	0.41574	AGG	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	140.997894	KEEP		-	144.715465	0.762712	45	14	---	---	---	---	1	1	156	14	0	114	54	15	0	114	2	1	1	1070	133	0	1323	54	15	0	114	2	TP
CHD3	1107	broad.mit.edu	37	17	7811263	7811263	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr17:7811263G>A	ENST00000380358.4	+	34	5256	c.5255G>A	c.(5254-5256)cGg>cAg	p.R1752Q	CHD3_ENST00000330494.7_Missense_Mutation_p.R1693Q|SCARNA21_ENST00000517026.1_RNA|CHD3_ENST00000358181.4_Missense_Mutation_p.R1659Q	NM_001005271.2	NP_001005271.2	Q12873	CHD3_HUMAN	chromodomain helicase DNA binding protein 3	1693	Required for interaction with PCNT.	NA		NA	chromatin modification|regulation of transcription from RNA polymerase II promoter|transcription, DNA-dependent	microtubule organizing center|NuRD complex	ATP binding|ATP-dependent DNA helicase activity|DNA binding|protein binding|zinc ion binding			breast(2)|central_nervous_system(1)|cervix(2)|endometrium(11)|kidney(6)|large_intestine(13)|liver(2)|lung(14)|ovary(1)|pancreas(1)|prostate(7)|skin(3)|urinary_tract(2)	65		Prostate(122;0.202)				GATGAGCCACGGTCCAATGGG	0.567	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													109	102	104	NA	NA	NA	NA	17		NA								NA			NA				7811263		2203	4300	6503	SO:0001583	missense			ENSG00000170004	HGNC:1918	NM_001005273	Approved	uc002gjd.2	NA	D3DTQ9|Q9Y4I0	ENST00000380358.4	37	CCDS32553.2	.	.	.	.	.	.	.	.	.	.	G	12.84	2.057060	0.36277	.	.	ENSG00000170004	ENST00000380358;ENST00000358181;ENST00000330494;ENST00000439235	D;D;D	0.89810	-2.57;-2.51;-2.51	4.83	4.83	0.62350	.	0.000000	0.40554	N	0.001073	T	0.71634	0.3363	N	0.08118	0	0.33582	D	0.599998	B;P;P;P	0.41420	0.136;0.702;0.749;0.517	B;B;B;B	0.31495	0.011;0.13;0.131;0.065	T	0.76898	-0.2789	10	0.17369	T	0.5	-19.3747	10.4508	0.44520	0.0902:0.0:0.9098:0.0	.	270;1659;1693;1752	B3KWV4;Q12873-2;Q12873;E9PG89	.;.;CHD3_HUMAN;.	Q	1752;1659;1693;21	ENSP00000369716:R1752Q;ENSP00000350907:R1659Q;ENSP00000332628:R1693Q	ENSP00000332628:R1693Q	R	+	2	0	CHD3	7751988	0.004000	0.15560	1.000000	0.80357	0.998000	0.95712	1.612000	0.36889	2.509000	0.84616	0.561000	0.74099	CGG	CHD3-003	NOVEL	not_organism_supported|basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000318052.1	174.877673	KEEP		+	177.790607	0.362069	63	111	---	---	---	---	1	1	45	55	0	209	73	125	0	209	2	0	0	0	0	0	0	73	125	0	209	2	TP
ABCA8	10351	broad.mit.edu	37	17	66924136	66924136	+	Silent	SNP	A	A	T			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr17:66924136A>T	ENST00000269080.2	-	9	1331	c.1194T>A	c.(1192-1194)atT>atA	p.I398I	ABCA8_ENST00000586539.1_Silent_p.I398I|ABCA8_ENST00000430352.2_Silent_p.I398I	NM_007168.2	NP_009099.1	O94911	ABCA8_HUMAN	ATP-binding cassette, sub-family A (ABC1), member 8	398		NA		NA		integral to membrane|plasma membrane	ATP binding|ATPase activity, coupled to transmembrane movement of substances			breast(3)|central_nervous_system(2)|endometrium(9)|kidney(5)|large_intestine(19)|liver(1)|lung(30)|ovary(3)|pancreas(2)|prostate(2)|skin(3)|urinary_tract(4)	83	Breast(10;4.56e-13)					TTGTTGCTACAATGAGATTTG	0.328	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													66	67	67	NA	NA	NA	NA	17		NA								NA			NA				66924136		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000141338	HGNC:38	NM_007168	Approved	uc002jhp.3	NA	Q86WW0	ENST00000269080.2	37	CCDS11680.1																																																																																			ABCA8-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000450172.1	264.738398	KEEP		-	273.773917	0.819149	77	17	---	---	---	---	1	0.9999989	7	4	0	131	94	19	0	131	2	0	0	0	0	0	0	94	19	0	131	2	TP
RFX1	5989	broad.mit.edu	37	19	14079442	14079442	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr19:14079442C>T	ENST00000254325.4	-	12	1901	c.1667G>A	c.(1666-1668)gGg>gAg	p.G556E		NM_002918.4	NP_002909.4	P22670	RFX1_HUMAN	regulatory factor X, 1 (influences HLA class II expression)	556		NA		NA	immune response	nucleus	DNA binding|protein binding|sequence-specific enhancer binding RNA polymerase II transcription factor activity			NS(1)|breast(1)|endometrium(3)|kidney(1)|large_intestine(2)|lung(8)|ovary(2)|pancreas(1)|skin(1)|upper_aerodigestive_tract(1)	21			OV - Ovarian serous cystadenocarcinoma(19;6.67e-23)			CGGCTGCTGCCCCACCGCCAC	0.662	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													59	64	62	NA	NA	NA	NA	19		NA								NA			NA				14079442		2203	4298	6501	SO:0001583	missense				HGNC:9982	NM_002918	Approved	uc002mxv.3	NA		ENST00000254325.4	37	CCDS12301.1	.	.	.	.	.	.	.	.	.	.	C	14.82	2.650606	0.47362	.	.	ENSG00000132005	ENST00000254325	T	0.59502	0.26	5.33	5.33	0.75918	.	0.419611	0.26855	N	0.022155	T	0.59985	0.2234	M	0.66939	2.045	0.35726	D	0.817566	P	0.47409	0.895	P	0.45232	0.474	T	0.70802	-0.4773	10	0.44086	T	0.13	-34.6237	13.5261	0.61594	0.0:0.843:0.157:0.0	.	556	P22670	RFX1_HUMAN	E	556	ENSP00000254325:G556E	ENSP00000254325:G556E	G	-	2	0	RFX1	13940442	0.955000	0.32602	1.000000	0.80357	0.451000	0.32288	3.131000	0.50515	2.503000	0.84419	0.561000	0.74099	GGG	RFX1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000458510.1	66.831381	KEEP		-	68.438495	0.35	28	52	---	---	---	---	1	0.9887277	6	11	0	145	48	93	0	145	2	0	0	0	0	0	0	48	93	0	145	2	TP
MMP9	4318	broad.mit.edu	37	20	44639814	44639814	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-28-5216-Tumor-SM-1QEUG	GBM-TCGA-28-5216-Normal-SM-1QETB	g.chr20:44639814G>A	ENST00000372330.3	+	5	701	c.682G>A	c.(682-684)Gcg>Acg	p.A228T	RP11-465L10.10_ENST00000535913.1_RNA	NM_004994.2	NP_004985.2	P14780	MMP9_HUMAN	matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)	228	Fibronectin type-II 1.	NA		NA	collagen catabolic process|macrophage differentiation|positive regulation of keratinocyte migration|proteolysis	extracellular space|proteinaceous extracellular matrix	collagen binding|metalloendopeptidase activity|zinc ion binding			breast(2)|endometrium(4)|large_intestine(14)|liver(2)|lung(17)|ovary(1)|pancreas(1)|prostate(1)|skin(1)|urinary_tract(3)	46		Myeloproliferative disorder(115;0.0122)			Glucosamine(DB01296)|Marimastat(DB00786)|Minocycline(DB01017)|Simvastatin(DB00641)	CGCAGATGGCGCGGCCTGCCA	0.637	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													94	105	102	NA	NA	NA	NA	20		NA								NA			NA				44639814		2203	4300	6503	SO:0001583	missense			ENSG00000100985	HGNC:7176		Approved	uc002xqz.3	NA	B2R7V9|Q3LR70|Q8N725|Q9H4Z1|Q9UCJ9|Q9UCL1|Q9UDK2	ENST00000372330.3	37	CCDS13390.1	.	.	.	.	.	.	.	.	.	.	G	34	5.395562	0.96009	.	.	ENSG00000100985	ENST00000372330	T	0.10099	2.91	4.56	4.56	0.56223	Peptidase M10, metallopeptidase (1);Fibronectin, type II, collagen-binding (3);Kringle-like fold (1);Peptidase, metallopeptidase (1);	0.103114	0.64402	D	0.000002	T	0.25865	0.0630	M	0.85710	2.77	0.80722	D	1	D	0.53885	0.963	P	0.48270	0.572	T	0.15206	-1.0445	10	0.54805	T	0.06	.	16.8574	0.86009	0.0:0.0:1.0:0.0	.	228	P14780	MMP9_HUMAN	T	228	ENSP00000361405:A228T	ENSP00000361405:A228T	A	+	1	0	MMP9	44073221	1.000000	0.71417	0.980000	0.43619	0.974000	0.67602	5.388000	0.66249	2.514000	0.84764	0.650000	0.86243	GCG	MMP9-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000080337.1	484.219028	KEEP		+	489.173915	0.644444	174	96	---	---	---	---	1	1	4	49	0	371	211	154	0	371	2	0	0	0	0	0	0	211	154	0	371	2	TP
